Digital mental healthcare provider Koa Health has unveiled its new scientific advisory board. The advisory board, chaired by Tom Insel, consists of seven healthcare experts across the fields of mental health, psychiatry, psychology and technology.
The full roster consists of:
- Tom Insel, former director of the National Institute of Mental Health (NIMH) and expert in mental health research, policy and technology
- Patricia Arean, professor at the University of Washington’s department of psychiatry and behavioral science
- Beth Rogozinski, CEO of Oncoustics, an innovative AI solutions company. Past CPO at Pear Therapeutics
- Sabine Wilhelm, chief of psychology at Massachusetts General Hospital (MGH), and professor at Harvard Medical School
- David Clark, professor and chair of experimental psychology at the University of Oxford
- Peter Fonagy, University College London’s (UCL) head of the division of psychology and language sciences, and chief executive of the Anna Freud Centre
- Steve Pilling, professor of clinical psychology and head of the department of clinical, education and health psychology at UCL
Koa Health said the new board would support its ambitions to provide holistic solutions for the rapidly growing demand for digital mental health products. The news comes shortly after Koa Health launched its Wellbeing at Work report, which exposed the impact of Covid-19 on mental health in businesses across the US and UK.
Oliver Harrison, CEO of Koa Health, said: ‘We are delighted to work with such experienced advisers who are supporting our efforts to bring mental wellbeing to everyone. It’s clear that digital technology has the potential to help close the growing demand gap for mental healthcare exacerbated by the COVID-19 pandemic, but the technology has to be effective, engaging in real-world situations, and accessible at scale. Our scientific advisory board help ensure we deliver against these key dimensions.’
Commenting on the announcement, Insel said: ‘There are many opportunities to apply technology to the global mental healthcare shortage, providing access to vital services which are in growing demand. However, access is just one piece of the puzzle. I’m excited to be joining Koa Health’s scientific advisory board as chair because the company is focused on addressing the issue of quality. Done correctly, the field of digital mental health could transform mental health treatment and diagnosis and improve people’s lives. I believe Koa Health’s approach to develop solutions, which are personalised and backed by science, can do just that.’